Effect of remimazolan on postoperative delirium in elderly patients undergoing lung cancer surgery: a prospective noninferiority randomized controlled study

Authors
Category Primary study
Registry of TrialsChinese Clinical Trial Register
Year 2023
INTERVENTION: Propofol group:Propofol;Remimazolan group:Remimazolan; CONDITION: thoracic disease PRIMARY OUTCOME: incidence of postoperative delirium; SECONDARY OUTCOME: duration of PACU;number of delirium;postoperative hospital days;the Mini‐mental State Examination (MMSE) score was obtained 30 days after operation; INCLUSION CRITERIA: 1. Aged >65 years; 2. Patients undergoing elective thoracoscopic or open surgical resection of lung segment, lung lobe or lung; 3. ASA ?‐?; 4. Recovery after admission to PACU; 5. Length of stay >=1 day after surgery; 6. The estimated operation duration is >=1h.
Epistemonikos ID: 86ac2bca1fb9d7171284b79ce6d70a4ef06dbf25
First added on: Feb 20, 2024